A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing Potential
Part of paid clinical trials in Brooklyn, Maryland.
- Sponsor
- AstraZeneca
- Study ID
- NCT06657105
- Phase
- PHASE1
- Status
- Completed
Conditions
- Healthy Participants
Eligibility Criteria
- Sex
- FEMALE
- Age
- 35 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- EE/LNG — DRUGEE/LNG tablet will be administered orally.
- Baxdrostat — DRUGBaxdrostat tablet will be administered orally.
Study Details
The main purpose of the study is to assess the effect of multiple doses of baxdrostat on the pharmacokinetics (PK) of a single dose of combined oral ethinyl estradiol (EE) and levonorgestrel (LNG). Safety and tolerability of baxdrostat will be assessed during the study.
Key Dates
- Start date
- Nov 1, 2024
- Status verified
- Feb 2025
- Primary completion
- Feb 3, 2025
- Completion
- Feb 3, 2025
Study Design
- Enrollment
- 22 participants (actual)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- OTHER
Arms
- Experimental: Period 1: Ethinyl estradiol/Levonorgestrel (EE/LNG)Participants will receive oral dose of EE/LNG in the fasted state on Day ,1 followed by PK sampling of EE/LNG for 120 hours (EE 72 hours and LNG 120 hours).
- Experimental: Period 2: BaxdrostatParticipants will self-administer the baxdrostat tablet once a day from Day 6 to Day 16.
- Experimental: Period 3: Baxdrostat + EE/LNGParticipants will receive baxdrostat once daily on Day 17 to Day 22 and will receive EE+LNG in the fasted state on Day 18, followed by oral dose of EE/LNG PK sampling for 120 hours (EE=72 hours and LNG=120 hours).
Primary Outcome Measure
Area under concentration-time curve from time zero to infinity (AUCinf) [ Time Frame: EE: Up to Day 21, LNG: Up to Day 23 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Research Site | Brooklyn | Maryland | 21225 | - |
Find similar trials in Brooklyn, MD
By research site
Related Studies
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With DyslipidemiaPHASE1 · Recruiting · AstraZeneca · Glendale, California
- A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or ObesityPHASE1 · Recruiting · AstraZeneca · Glendale, California
- Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEEP)PHASE1 · Recruiting · Johns Hopkins University · Baltimore, Maryland
- A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy ParticipantsPHASE1 · Recruiting · AstraZeneca · Glendale, California